Linsitinib is a small-molecule dual insulin-like growth factor-1 receptor (IGF-IR) and insulin receptor (IR) kinase inhibitor. IGF-I receptor (IGF-IR) has been implicated in the promotion of tumorigenesis, metastasis and resistance to cancer therapies and thus Linsitinib may be a useful anticancer agent. Appearance: White to off-white crystalline solid Purity: 99% (HPLC, TLC) Solubility: DMSO, 50mg/ml Melting Point: 233-237C
Molekulargewicht:
421.49
Reinheit:
99% (HPLC, TLC)
Formulierung:
White to off-white crystalline solid
CAS Nummer:
[867160-71-2]
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten